- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.05. | Facing 'uncertainty on steroids,' biotech dealmakers tread more cautiously | ||
| 06.05. | Trump orders FDA to help speed building of new drug factories | ||
| 06.05. | Bluebird pleads for deal support; Unity, Mersana lay off staff | ||
| 05.05. | PTC stock slides on new data for Huntington's drug | ||
| 05.05. | AI specialist Recursion trims pipeline in latest shakeup | ||
| 05.05. | Deerfield secures more than $600M for its next biotech venture fund | ||
| 02.05. | Amgen's Stelara biosimilar gets off to fast start | ||
| 02.05. | Cytokinetics reveals unexpected delay; AstraZeneca combo therapy hits in asthma | ||
| 01.05. | Moderna combination flu, COVID shot delayed amid FDA scrutiny | ||
| 01.05. | Pharma downplays tariff threat, even as risks remains unclear | ||
| 01.05. | CVS strikes Wegovy deal with Novo Nordisk | ||
| 01.05. | Arvinas, Entrada cut staff; Merck builds US hub for Keytruda | ||
| 01.05. | AstraZeneca quietly exits neuroscience | ||
| 01.05. | Madrigal's MASH drug sales again top Wall Street projections | ||
| 01.05. | Siren, a gene therapy startup, tests unconventional alternative to venture funding | ||
| 30.04. | Novartis to acquire Regulus in deal for kidney disease drug | ||
| 30.04. | J&J secures FDA OK for immune drug touted as future blockbuster | ||
| 30.04. | BridgeBio sales of new heart drug outstrip expectations | ||
| 29.04. | Acelyrin should liquidate instead of merging with Alumis, investor says | ||
| 29.04. | Pfizer's Bourla 'cautiously optimistic' on looming US pharma tariffs | ||
| 29.04. | Novo partners with telehealth companies in move to expand Wegovy market | ||
| 29.04. | FDA misses approval deadline for biotech's rare disease drug | ||
| 29.04. | Abeona cell therapy approved by FDA for rare skin condition | ||
| 28.04. | Novavax says vaccine application still 'approvable,' despite FDA delay | ||
| 28.04. | Merck KGaA to buy biotech SpringWorks for $3.9B |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .